Glial fibrillary acidic protein as a biomarker for visuospatial ability in Down syndrome
These preliminary results indicate that GFAP may be a useful plasma biomarker for visuospatial ability level in adults with DS. Continuing this research holds potential for enhancing early detection of AD-related cognitive impairment. Future analyses should assess correlations longitudinally and compare correlations to those of DS individuals with cognitive impairment.
Authors
- Jennifer L. Bruno (ORCID: https://orcid.org/0000-0001-7705-2456)
- Anna Kiesewetter
Institutions
- Stanford University (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70861_108368
- Primary Topic
- Down syndrome and intellectual disability research
- Type
- article
- Field-Weighted Citation Impact
- 0.00